Georgia McGaughey, Ph.D.

Dr. Georgia McGaughey brings more than three decades of experience in computational sciences, research strategy, and digital transformation for drug discovery. She currently advises companies on accelerating innovation through Trilligant, a consultancy she founded in 2024. Prior to this, Dr. McGaughey spent nearly 12 years at Vertex Pharmaceuticals, most recently as Vice President of the Global Data and Computational Science group and as a member of the Research Leadership Team responsible for scientific strategy and direction across the company’s portfolio. Before Vertex, she spent 13 years at Merck in roles spanning multiple therapeutic areas, including infectious diseases and neurosciences. Her work has contributed to the invention and advancement of several drug candidates and has resulted in more than 100 publications and presentations. Dr. McGaughey earned a B.S. in chemistry from Kennesaw State University and a Ph.D. in physical chemistry from the University of Georgia, followed by postdoctoral research in electronic structure theory at Colorado State University, and is also a graduate of multiple executive leadership programs at Harvard Business School.